Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBbva Ord Regulatory News (BVA)

Share Price Information for Bbva Ord (BVA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.13
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.44 (4.938%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 9.13
BVA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BBVA Dividend option

11 Apr 2012 18:22

RNS Number : 1696B
Banco Bilbao Vizcaya Argentaria SA
11 April 2012
 

 

 

Banco Bilbao Vizcaya Argentaria, S.A.(BBVA), in compliance with the Securities Market legislation, hereby communicates the following:

 

 

 

RELEVANT EVENT

In connection with the relevant event of March 28, 2012 (Filing No. 160866), BBVA hereby submits, for purposes of articles 26.1.e) and 41.1.d) of Royal Decree 1310/2005 of November 4, this supplementary document to the Information Document relating to the free-of-charge capital increase by which a system of flexible shareholder remuneration called "Dividend Option" is to be instrumented.

 

Madrid, April 11, 2012

 

supplementary document to the Information Document

 

CAPITAL INCREASE CHARGED TO VOLUNTARY RESERVES

 

BANCO BILBAO VIZCAYA ARGENTARIA, S.A.

 

 

April 11, 2012

 

  

THIS DOCUMENT HAS BEEN PREPARED IN ACCORDANCE WITH ARTICLES 26.1.E) AND 41.1.D) OF ROYAL DECREE 1310/2005 OF NOVEMBER 4.

 

Disclaimer: The English version is a free translation of the original in Spanish for information purposes only. In the event of discrepancy, the Spanish original will prevail

1. INTRODUCTION

This document (the "Supplementary Document") has been issued to supplement the information provided in the information document relating to the capital increase charged to voluntary reserves approved by the ordinary general shareholders' meeting of Banco Bilbao Vizcaya Argentaria, S.A. ("BBVA" or the "Bank") held on March 16, 2012, under item 4.1 of the fourth point of its agenda (the "Capital Increase"), which was published by means of a relevant event on March 28, 2012, with filing number 160866 (the "Information Document"). Capitalized terms used but not defined herein have the meanings assigned to them in the Information Document.

This Supplementary Document sets forth below the information relating to the Capital Increase which was outstanding at the date of publication of the Information Document and, in particular, the number of shares to be issued (with the possibility of incomplete subscription being expressly provided for), the number of free allotment rights necessary to receive one new share ("NAR") and the price at which BBVA has undertaken to acquire free allotment rights from shareholders, in the terms set forth in the Information Document.

This Supplementary Document and the Information Document have been issued in accordance with articles 26.1.e) and 41.1.d) of Royal Decree 1310/2005, of November 4, which provide that the preparation and publication of a prospectus related to the issuance and admission to listing of the shares issued as a consequence of the execution of the Capital Increase will not be necessary "provided that a document is made available containing information on the number and nature of the shares and the reasons for and details of the offer". This Supplementary Document together with the Information Document constitute such document. This Supplementary Document and the Information Document are available on the CNMV's website (www.cnmv.es) and the Bank's website (www.bbva.com).

2. SUPPLEMENTARY INFORMATION TO THE INFORMATION DOCUMENT

The Executive Committee of BBVA, in its meeting held on April 11, 2012, has agreed to implement the Capital Increase in accordance with the terms approved by the ordinary general shareholders' meeting of BBVA held on March 16, 2012, under item 4.1 of the fourth point of its agenda, and by the Board of Directors of BBVA, in its meeting held on March 28, 2012. In accordance with the formulas approved by these bodies, the Executive Committee has approved the following parameters concerning the Capital Increase:

(i) The number of new shares to be issued as a consequence of the execution of the Capital Increase ("New Shares") will be 107,682,603 New Shares. Accordingly, the aggregate nominal value of the Capital Increase will be €52,764,475.47, which is the product of multiplying the number of New Shares 107,682,603 by the nominal value of €0.49 per New Share.

The number of New Shares to be issued is the result of applying the formulas provided for in the applicable resolution adopted by the ordinary general shareholders' meeting of BBVA held on March 16, 2012, under item 4.1 of the fourth point of its agenda, and by the Board of Directors of BBVA, in its meeting held on March 28, 2012, considering that the number of old shares outstanding is 5,061,082,3781 ("NOS"), that the reference market value is €615,000,000 ("RMV") and that the reference price is €5.677 ("reference price" or "RP").2 On this basis:

(a) The number of rights to be assigned ("rights to be assigned" or "NAR") is 47, in accordance with the formula in the shareholders' and board's resolutions (rounded up to the nearest whole number):

NAR = RP x NOS / RMV

which, as applied, results in:

NAR = €5.677 x 5,061,082,378 / 615,000,000 = 47

(b) The number of New Shares to be issued is 107,682,603 New Shares, in accordance with the formula in the shareholders' and board's resolutions (rounded down to the nearest whole number):

New Shares = NOS / NAR

which, as applied, results in:

New Shares = 5,061,082,378 / 47 = 107,682,603

Notwithstanding this, the number of New Shares actually issued and, as a result, the nominal value of the Capital Increase may be less than the foregoing depending on the number of rights acquired by the Bank pursuant to its undertaking to acquire the free allotment rights for a fixed price. BBVA will waive the free allotment rights acquired pursuant to such undertaking. As a result, only those shares corresponding to the free allotment rights which have not been acquired by BBVA pursuant to its undertaking will be issued.

The New Shares will be issued at their nominal value of forty-nine euro cents (€0.49) per New Share, without issuance premium.

1 This amount reflects the voluntary conversion into shares, at the option of the holders, of BBVA’s mandatory convertible subordinated bonds issued in December 2011, after which the number of old shares outstanding is 5,061,082,378.
2 The Reference Price corresponds to the arithmetic mean of the weighted average prices of BBVA’s shares on the Spanish Stock Exchanges (Mercado Continuo) over the five trading sessions immediately prior to April 11, 2012, the date that BBVA’s Executive Committee resolved to effect the Capital Increase, rounded to the nearest thousandth of a euro and, in the case of a half of a thousandth of a euro, the immediately higher thousandth of a euro. 

(ii) The number of rights necessary to receive one New Share is 47.

BBVA shareholders who appear as such in the book-entry registries of Sociedad de Gestión de los Sistemas de Registro, Compensación y Liquidación de Valores, S.A. ("Iberclear") at 23:59 Madrid time on the day of publication of the announcement of the Capital Increase in the Official Bulletin of the Commercial Registry ("Boletín Oficial del Registro Mercantil") (envisaged for April 13, 2012) will receive a free allotment right for each BBVA share held. Consequently, such shareholders will have a right to receive one New Share for each 47 shares held by them on such date.

To ensure that all free allotment rights are effectively exercisable and that the number of New Shares to be issued is a whole number, BBVA has renounced 37 rights corresponding to 37 shares held as treasury shares.

(iii) The fixed purchase price of each freely allotted right assumed by BBVA is €0.118 per right, in accordance with the formula approved by the ordinary general shareholders' meeting of BBVA held on March 16, 2012, under item 4.1 of the fourth point of its agenda, and by the Board of Directors of BBVA, in its meeting held on March 28, 2012 (rounded to the nearest thousandth of a euro and, in the case of a half of a thousandth of a euro, the immediately higher thousandth of a euro):

Purchase price = RP / (NAR +1)

which, as applied, results in:

Purchase price = 5.677 / (47 + 1) = €0.118

Accordingly, shareholders who wish to receive a dividend in cash can sell their rights to BBVA at a gross fixed price of €0.118 per right.

As indicated in the Information Document, this option is granted exclusively to the shareholders of BBVA who have such condition at the time the free allotment rights are allocated and only in connection with the free allotment rights which are originally allocated to them at such time; accordingly, this option will not be available in respect of any free allotment right acquired through a market purchase.

BBVA's undertaking to acquire rights at this fixed price will be in effect from the first trading day of the rights, which is expected to take place on April 16, 2012 through April 25, 2012, both inclusive.3

3 The options, terms and procedures indicated in this information document may not be the same in respect of BBVA shares listed outside Spain, including in the form of BBVA ADSs.

* * *

Banco Bilbao Vizcaya Argentaria, S.A.

P.p.

Erik Schotkamp

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCIBMRTMBBBBTT
Date   Source Headline
20th Apr 20212:21 pmRNSResolutions SGM 2021
17th Mar 20217:00 amRNSPre-Stabilisation Notice - BBVA
16th Mar 20217:36 amRNS2021 AGM Proposed Resolutions
16th Mar 20217:00 amRNSCash payment against share premium acc. calendar
15th Mar 20216:06 pmRNS2021 Annual General Meeting Call
12th Mar 20215:01 pmRNSBasel Accord Pillar III 2020
3rd Mar 20215:07 pmRNSEarly redemption of preferred securities
29th Jan 20217:00 amRNS4Q20 Quarterly Report
29th Jan 20217:00 amRNS4Q20 Results Press Release
29th Jan 20217:00 amRNS4Q20 Results Report
29th Jan 20217:00 amRNSShareholders' Remuneration
25th Jan 20217:00 amRNS2021 BBVA has completed the sale of BBVA Paraguay
20th Jan 20215:08 pmRNS4Q20 Results Presentation Announcement
14th Dec 20205:21 pmRNSAgreement with Allianz
27th Nov 20207:00 amRNSEnd of conversations with Banco de Sabadell
16th Nov 20205:13 pmRNSConversations with Banco de Sabadell, S.A.
16th Nov 20207:00 amRNSPresentation_Sale of BBVA's U.S. subsidiary to PNC
16th Nov 20207:00 amRNSSale of BBVA's U.S. subsidiary to PNC
30th Oct 20207:21 amRNS3Q20 Results Presentation
30th Oct 20207:09 amRNS3Q20 Quarterly Report
30th Oct 20207:05 amRNS3Q20 Results Press Release
21st Oct 20205:06 pmRNS3Q20 Results Presentation Announcement
23rd Sep 20207:48 amRNSBBVA CEO Presentation
14th Aug 20209:00 amRNSPost-Stab Notice BBVA GBP 300m
30th Jul 20207:00 amRNS2Q20 Results Presentation
30th Jul 20207:00 amRNS2Q20 Results Report
30th Jul 20207:00 amRNS2Q20 Results Press Release
21st Jul 20204:57 pmRNS2Q20 Results Presentation Announcement
14th Jul 202012:12 pmRNSPre-Stab Notice BBVA GBP 300m due 15th July
7th Jul 20205:20 pmRNSOffer of securities convertible into shares_2
7th Jul 20208:23 amRNSOffer of securities convertible into shares
3rd Jul 202010:34 amRNSPost-stab Notice BBVA EUR 1bn
23rd Jun 20207:00 amRNSFitch Rating Update
27th May 20205:41 pmRNSPre-Stab Notice BBVA EUR 1BN due 4th June 2020
30th Apr 20207:28 amRNS1Q20 Results Press Release
30th Apr 20207:05 amRNSNew Composition BD Committees
30th Apr 20207:05 amRNS1Q20 Results Report
30th Apr 20207:00 amRNS1Q20 Results Presentation
30th Apr 20207:00 amRNSDividend Policy
28th Apr 20207:00 amRNSAgreement between BBVA and Allianz
21st Apr 20205:00 pmRNS1Q20 Results Presentation Announcement
9th Apr 20208:21 amRNSPotential Note Purchase
16th Mar 20207:00 amRNSPrudential Relevance Report (Pillar III) 2019
13th Mar 20203:12 pmRNSResolutions adopted by the AGM 2020
10th Mar 20205:30 pmRNSBBVA Statement to Shareholders 2020 AGM
12th Feb 20208:50 amRNS2020 AGM Proposed Resolutions
11th Feb 20207:00 amRNSFinal dividend calendar 2019
10th Feb 20205:33 pmRNS2020 AnnualGeneral Meeting Call
5th Feb 20204:26 pmRNSPost Stabilisation Notice - BBVA S.A.
31st Jan 20207:28 amRNS4Q19 Results Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.